Oral dut 0.5mg and oral minoxidil 5mg
    3/25/2026

    From the encyclopedia
    Dutasteride →

    Heavy duty finasteride that comes with higher risks

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Dutasteride (oral) 0.5mg daily 4.5 months
    💊 Minoxidil (oral) 5mg daily 2 months
    💧 Minoxidil (topical)
    💧 Finasteride solution (topical) 5% & 0.25%
    💧 Tazarotene (topical) alternate days
    💧 Calcipotriol (topical) 0.005% every other day
    • Microneedling 1.5mm every 5-7 days
    💧 Peptide serum (topical) after microneedling
    the tone is concerned.

    Other terms

    The user is using oral dutasteride, oral minoxidil, topical minoxidil, finasteride solution, tazarotene, calcipotriol, and a peptide serum for hair loss but is concerned about continued hair shedding. They are advised to stop smoking as it may worsen hair loss and to give the treatments more time to work.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

      community Results after 3 years on Fin and Min

      in Progress Pictures  143 upvotes 1 year ago
      The user has been using oral finasteride and topical minoxidil for three years, seeing some regrowth initially but mostly maintenance afterward. Suggestions for further improvement include trying dutasteride, RU58841, or a hair transplant.

      community What is the ultimate hair regrowth protocol

       29 upvotes 1 year ago
      The conversation covers aggressive hair regrowth treatments like Dutasteride, Minoxidil (oral and topical), RU58841, microneedling, and ketoconazole shampoo. It also mentions PRP, laser therapy, GHK-Cu injections, and hormone therapy for maximum regrowth.

      community is anyone using ru58841 against acne?

      in Technology  3 upvotes 1 year ago
      RU58841 is discussed as a potential treatment for acne and hair loss, with users debating its effectiveness and safety compared to other treatments like finasteride, minoxidil, and dutasteride. Concerns about RU58841's side effects and lack of clinical trials are raised, while some users share their personal experiences and routines involving RU58841 for hair loss.

      community Oral daily 1 mg dutasteride with Minoxidil topical solution

      in Minoxidil  4 upvotes 4 months ago
      Oral dutasteride and topical Minoxidil are used to treat hair loss, with the goal of suppressing DHT and improving hair density. The effectiveness depends on genetics and the duration of baldness, and lifelong treatment may be necessary to maintain results.

    Related Research

    6 / 6 results

      research Hair follicle-targeting drug delivery strategies for the management of hair follicle-associated disorders

      14 citations , May 2022 in “Asian Journal of Pharmaceutical Sciences”
      This review article highlights how hair follicle-targeting drug delivery systems enhance therapeutic outcomes and reduce side effects for treating conditions like androgenetic alopecia and acne vulgaris. The authors discuss current formulations and evaluate their performance in both preclinical and clinical settings.

      research Cicatricial Alopecia

      2 citations , January 2015 in “Springer eBooks”
      Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

      research Primary cicatricial alopecias

      1 citations , April 2010 in “Expert Review of Dermatology”
      This review discusses primary cicatricial alopecias, detailing their classification, pathogenesis, clinical features, histopathologic findings, and treatment, without reporting new experimental results.

      research Cosmetic Approach for Men

      January 2017 in “Clinical approaches and procedures in cosmetic dermatology”
      This chapter reviews differences in dermatological treatments and conditions between male and female patients, particularly noting the impacts of sex steroids on various skin processes, but presents no new clinical findings.